Results 181 to 190 of about 13,843 (217)
Some of the next articles are maybe not open access.

Evaluation of hematological inflammatory parameters in patients with palmoplantar pustulosis

International Journal of Dermatology
Palmoplantar pustulosis (PPP) is a chronic inflammatory disease of ill‐defined etiopathology. Recent studies have proposed complete blood count‐based hematological parameters, such as neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR),
Xin Ning   +4 more
semanticscholar   +1 more source

Palmoplantar Pustulosis: Therapy Update.

Journal of Drugs in Dermatology
Palmoplantar pustulosis is a variant of psoriasis and a chronic skin disorder in which pruritic pustular eruptions appear on the palms and soles. It is thought to arise from a variety of genetic and environmental factors, is limited in prevalence, and ...
S. Devjani   +5 more
semanticscholar   +1 more source

Retrospective study of the clinical significance of the neutrophil‐to‐lymphocyte ratio in 79 patients with palmoplantar pustulosis

Journal of dermatology (Print)
Palmoplantar pustulosis (PPP) is a chronic relapsing inflammatory skin disease characterized by multiple vesicles, pustules, and erythematous plaques on the palms and soles.
Tomoya Watanabe   +5 more
semanticscholar   +1 more source

Tonsils: the next frontier in the treatment of palmoplantar pustulosis.

EJD. European journal of dermatology
Palmoplantar pustulosis (PPP) is a chronic relapsing inflammatory disease of unknown aetiology characterized by erythema, scaling, and aseptic pustules, which pose a significant clinical, psychological, and economic burden to patients. Studies have shown
Rui Fan   +7 more
semanticscholar   +1 more source

Local injection of micro‐dose guselkumab for palmoplantar pustulosis after partial failure of systemic ixekizumab treatment

Australasian Journal of Dermatology
We present a palmoplantar pustulosis case partially resistant to systemic IL‐17A inhibitor (ixekizumab) treatment, and then receiving a local injection of 0.1 mL micro‐dose (1 mg) IL‐23 inhibitor (guselkumab) every 4 weeks for four times. The paradoxical
Chaojing Zhou   +5 more
semanticscholar   +1 more source

Management of palmoplantar pustulosis

Clinical and Experimental Dermatology, 2002
Palmoplantar pustulosis or chronic palmoplantar pustular psoriasis (PPP) is an uncommon but disabling and recalcitrant pustular dermatosis affecting the palms and soles. Its onset is strongly linked to cigarette smoking and once it is established it tends to progress gradually over years or decades. Its relationship to psoriasis is disputed.
openaire   +1 more source

Pustulosis palmoplantar

FMC - Formación Médica Continuada en Atención Primaria, 2014
Martín Debén Sánchez   +1 more
openaire   +1 more source

[Arthritis and palmoplantar pustulosis].

La Revue de medecine interne, 1987
Pustulosis palmaris et plantaris may be associated with a number of articular diseases. Known to be present in Fiessinger-Leroy-Reiter syndrome and psoriasis arthropatica, this skin disease has been classified by Japanese authors as a new nosological entity: pustular osteo-arthritis.
B, Bauduceau   +5 more
openaire   +1 more source

Clinical Outcome of Tonsillectomy for Palmoplantar Pustulosis and Etiological Relationship between Palmoplantar Pustulosis and Tonsils

2011
Palmoplantar pustulosis (PPP) is famous for causing typical tonsillar focal diseases. Clinical improvement of PPP rash after tonsillectomy was seen in 109 (94%) of 116 patients by subjective self-assessment, and 52 (88%) of 59 patients by objective Palmoplantar Pustulosis Area and Severity Index (PPPASI) scoring.
openaire   +2 more sources

<p>Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations</p>

Clinical, Cosmetic and Investigational Dermatology, 2020
Egidio Freitas   +2 more
exaly  

Home - About - Disclaimer - Privacy